• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型埃索沙星、依普菌素和吡喹酮复方制剂治疗猫栉首蚤性皮炎的疗效。

Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel against Notoedres cati mange in cats.

机构信息

Boehringer Ingelheim Vetmedica GmbH, Kathrinenhof Research Center, Walchenseestr. 8-12, 83101 Rohrdorf, Germany.

Kapriol Bt., Vak Bottyán St. 1, 8330 Sümeg, Hungary.

出版信息

Parasite. 2021;28:27. doi: 10.1051/parasite/2021023. Epub 2021 Apr 2.

DOI:10.1051/parasite/2021023
PMID:33812459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8019547/
Abstract

The therapeutic efficacy against notoedric mange of a topical combination of esafoxolaner, eprinomectin and praziquantel (Nexgard Combo, Boehringer Ingelheim) was evaluated in a masked, controlled clinical study including 14 cats with natural or induced Notoedres cati infestation. Cats were allocated randomly to two groups of seven cats each, to be administered either mineral oil (placebo control) or NexGard Combo. Each treatment was administered once as spot-on at 0.12 mL per kg body weight (representing the minimum label dosage of NexGard Combo, i.e. 1.44 mg esafoxolaner, 0.48 mg eprinomectin, and 10.0 mg praziquantel per kg body weight). Live mites were counted in skin scrapings collected within seven days prior to and 14, 27/28, 42 and 56 days after treatment to calculate the percentage efficacy of NexGard Combo based on the comparison of mean live mite counts of the two groups. Concurrently, mange lesions and clinical signs were scored to establish a clinical success valuation. No live mites were recovered from any NexGard Combo-treated cats post-treatment, indicating 100% therapeutic efficacy following a single spot-on administration of the novel antiparasitic combination. The clinical success valuations in the NexGard Combo-treated cats were 14.3%, 42.8%, 100% and 100% at 14, 27/28, 42 and 56 days after treatment, respectively. No health problems were observed throughout the study.

摘要

一项针对局部联合应用埃索昔拉菌素、依普菌素和吡喹酮(Nexgard Combo,勃林格殷格翰)治疗诺特氏痒螨病的疗效评估在一项有对照的临床研究中进行,该研究纳入了 14 只患有自然或诱导性猫诺特氏痒螨感染的猫。这些猫被随机分配到两组,每组 7 只,分别给予矿物油(安慰剂对照)或 Nexgard Combo。每种治疗方法均以 0.12 毫升/千克体重的剂量进行一次点涂(代表 Nexgard Combo 的最低标签剂量,即 1.44 毫克埃索昔拉菌素、0.48 毫克依普菌素和 10.0 毫克吡喹酮/千克体重)。在治疗前 7 天和治疗后 14、27/28、42 和 56 天采集皮肤刮片,计算活螨计数,以比较两组的平均活螨计数,计算 Nexgard Combo 的疗效百分比。同时,对螨病病变和临床症状进行评分,以建立临床疗效评估。Nexgard Combo 治疗的猫在治疗后均未检出活螨,单次点涂新型驱虫联合用药后,疗效达到 100%。Nexgard Combo 治疗的猫在治疗后 14、27/28、42 和 56 天的临床疗效评分分别为 14.3%、42.8%、100%和 100%。在整个研究过程中未观察到任何健康问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e74/8019547/0a6893222c63/parasite-28-27-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e74/8019547/0a6893222c63/parasite-28-27-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e74/8019547/0a6893222c63/parasite-28-27-fig1.jpg

相似文献

1
Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel against Notoedres cati mange in cats.新型埃索沙星、依普菌素和吡喹酮复方制剂治疗猫栉首蚤性皮炎的疗效。
Parasite. 2021;28:27. doi: 10.1051/parasite/2021023. Epub 2021 Apr 2.
2
Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel in cats against Toxocara cati and Dipylidium caninum.新型埃索昔拉菌素、依普菌素和吡喹酮复方滴剂对猫感染的弓首蛔虫和复孔绦虫的疗效。
Parasite. 2021;28:28. doi: 10.1051/parasite/2021024. Epub 2021 Apr 2.
3
Therapeutic efficacy of Broadline against notoedric mange in cats.博来恩对猫疥螨病的治疗效果。
Parasitol Res. 2014 Nov;113(11):4303-6. doi: 10.1007/s00436-014-4126-z. Epub 2014 Sep 26.
4
Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel against ear mite (Otodectes cynotis) infestations in cats.新型埃索昔拉菌素、依普菌素和吡喹酮复方滴剂治疗猫耳螨(耳痒螨)感染的疗效。
Parasite. 2021;28:26. doi: 10.1051/parasite/2021022. Epub 2021 Apr 2.
5
Efficacy of a topical formulation containing esafoxolaner, eprinomectin and praziquantel (NexGard Combo) against natural infestations with the cat louse, Felicola subrostratus under field conditions.在现场条件下,含有埃索非拉纳、依普菌素和吡喹酮的局部制剂( NexGard Combo )对猫栉首蚤自然感染的疗效。
Parasite. 2022;29:62. doi: 10.1051/parasite/2022062. Epub 2022 Dec 23.
6
Efficacy of two endectoparasiticide products combining fipronil and (S)-methoprene or esafoxolaner with eprinomectin and praziquantel against fleas and intestinal helminths in cats naturally infested in Brazil.两种含有氟虫腈和(S)-灭幼脲或埃索氯菊酯与伊维菌素和吡喹酮的体内驱虫产品对巴西自然感染跳蚤和肠道蠕虫的猫的疗效。
Parasite. 2022;29:12. doi: 10.1051/parasite/2022012. Epub 2022 Mar 3.
7
Pharmacokinetics of a novel endectoparasiticide topical formulation for cats, combining esafoxolaner, eprinomectin and praziquantel.新型猫用透皮驱虫药(埃索昔兰酮、依普菌素和吡喹酮复方制剂)的药代动力学。
Parasite. 2021;28:19. doi: 10.1051/parasite/2021014. Epub 2021 Apr 2.
8
Efficacy of a novel topical fipronil, (S)-methoprene, eprinomectin and praziquantel combination against naturally acquired intestinal nematode and cestode infections in cats.新型局部用氟虫腈、(S)-灭幼脲、伊维菌素和吡喹酮合剂对猫自然感染肠道线虫和绦虫的疗效。
Vet Parasitol. 2014 Apr 28;202(1-2):18-25. doi: 10.1016/j.vetpar.2014.02.033.
9
Efficacy of a combination of esafoxolaner, eprinomectin and praziquantel (NexGard Combo) against Thelazia callipaeda in naturally infected cats.埃索昔拉菌素、依普菌素和吡喹酮(NexGard Combo)组合对自然感染眼线虫的猫的疗效。
Parasite. 2024;31:10. doi: 10.1051/parasite/2024008. Epub 2024 Feb 28.
10
Efficacy of a topical combination of esafoxolaner, eprinomectin and praziquantel against Amblyomma maculatum infestations in cats.埃索沙星、依普菌素和吡喹酮复方制剂局部用药驱除猫栉首蚤感染的疗效。
Parasite. 2024;31:44. doi: 10.1051/parasite/2024044. Epub 2024 Aug 7.

引用本文的文献

1
Efficacy of a Topical Esafoxolaner, Eprinomectin and Praziquantel Combination Against Most Commonly Found Metazoan Parasites of Client-Owned Cats in Greece.一种外用埃沙氟拉尼、依普菌素和吡喹酮组合药物对希腊家养猫最常见后生动物寄生虫的疗效。
Vet Sci. 2025 Apr 19;12(4):385. doi: 10.3390/vetsci12040385.
2
Field efficacy and safety of Felpreva® (tigolaner, emodepside and praziquantel) spot-on for the treatment of natural ear mite infestations () and notoedric mange () in cats.福来恩(替诺拉纳、埃莫昔班和吡喹酮)滴剂治疗猫自然感染耳螨()和诺氏疥螨()的田间疗效及安全性。
Curr Res Parasitol Vector Borne Dis. 2023 Sep 23;4:100146. doi: 10.1016/j.crpvbd.2023.100146. eCollection 2023.
3

本文引用的文献

1
Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel against ear mite (Otodectes cynotis) infestations in cats.新型埃索昔拉菌素、依普菌素和吡喹酮复方滴剂治疗猫耳螨(耳痒螨)感染的疗效。
Parasite. 2021;28:26. doi: 10.1051/parasite/2021022. Epub 2021 Apr 2.
2
Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel against Amblyomma americanum in cats.新型埃索昔拉菌素、依普菌素和吡喹酮复方制剂治疗猫美洲钝眼蜱感染的疗效。
Parasite. 2021;28:25. doi: 10.1051/parasite/2021021. Epub 2021 Apr 2.
3
Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel against Rhipicephalus sanguineus in cats.
Isoxazolines for treating canine and feline otodectic mange; feline demodicosis, lynxacariasis, lice infestation, and notoedric mange (scabies); demodicosis in hamsters; and sarcoptic and psoroptic manges in rabbits.
异恶唑啉类药物用于治疗犬猫耳螨疥癣;猫蠕形螨病、豆状毛螨病、虱感染及背肛螨疥癣(疥疮);仓鼠蠕形螨病;以及兔的疥螨病和痒螨病。
Can Vet J. 2023 Nov;64(11):1066-1070.
4
Efficacy of a topical formulation containing esafoxolaner, eprinomectin and praziquantel (NexGard Combo) against natural infestations with the cat louse, Felicola subrostratus under field conditions.在现场条件下,含有埃索非拉纳、依普菌素和吡喹酮的局部制剂( NexGard Combo )对猫栉首蚤自然感染的疗效。
Parasite. 2022;29:62. doi: 10.1051/parasite/2022062. Epub 2022 Dec 23.
新型埃索昔拉菌素、依普菌素和吡喹酮复方滴剂治疗猫栉首蚤的疗效。
Parasite. 2021;28:24. doi: 10.1051/parasite/2021020. Epub 2021 Apr 2.
4
Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel against Ixodes ricinus and Ixodes scapularis in cats.新型埃索昔拉菌素、伊维菌素和吡喹酮复方制剂对猫体内硬蜱属和扇头蜱属的疗效。
Parasite. 2021;28:23. doi: 10.1051/parasite/2021019. Epub 2021 Apr 2.
5
Pharmacokinetics of a novel endectoparasiticide topical formulation for cats, combining esafoxolaner, eprinomectin and praziquantel.新型猫用透皮驱虫药(埃索昔兰酮、依普菌素和吡喹酮复方制剂)的药代动力学。
Parasite. 2021;28:19. doi: 10.1051/parasite/2021014. Epub 2021 Apr 2.
6
A synthetic review of notoedres species mites and mange.蠕形螨属螨类与疥疮的综合综述。
Parasitology. 2016 Dec;143(14):1847-1861. doi: 10.1017/S0031182016001505. Epub 2016 Sep 9.
7
Therapeutic efficacy of Broadline against notoedric mange in cats.博来恩对猫疥螨病的治疗效果。
Parasitol Res. 2014 Nov;113(11):4303-6. doi: 10.1007/s00436-014-4126-z. Epub 2014 Sep 26.
8
Treatment of naturally Notoedres cati-infested cats with a combination of imidacloprid 10 % / moxidectin 1 % Spot-on (Advocate® / Advantage® Multi, Bayer).使用含有 10%吡虫啉/1%莫昔克丁的滴剂(Advocate/Advantage Multi,拜耳)对自然感染栉首蚤的猫进行联合治疗。
Parasitol Res. 2013 Aug;112 Suppl 1:57-66. doi: 10.1007/s00436-013-3281-y.
9
Antimicrobial resistance and the guidelines of the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH).抗菌药物耐药性与《兽药注册技术要求国际协调合作组织(VICH)指南》
Rev Sci Tech. 2012 Apr;31(1):299-306. doi: 10.20506/rst.31.1.2113.
10
Macrocyclic lactones in the treatment and control of parasitism in small companion animals.大环内酯类药物在治疗和控制小型伴侣动物寄生虫病中的应用。
Curr Pharm Biotechnol. 2012 May;13(6):1078-94. doi: 10.2174/138920112800399167.